N-Acetyl Cysteine and Vitamin B12: study protocols
5 study groups took N-Acetyl Cysteine together with Vitamin B12. These are the doses the studies gave. They are not a recommendation.
Dose per serving from research: N-Acetyl Cysteine
5 study groups in 3 studies say how much N-Acetyl Cysteine participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 500 mg to 1 g, 60% of 5 study groups.
| Daily dose | Study groups |
|---|---|
| 100 mg to 250 mg | 2 |
| 250 mg to 500 mg | 0 |
| 500 mg to 1 g | 3 |
Commonly used together
5 of 5 study groups took N-Acetyl Cysteine and Vitamin B12 with something else, but nothing that 3 or more different studies gave.
5 study groups
| Study | ||||
|---|---|---|---|---|
| Lower rate of preeclampsia after antioxidant supplementation in pregnant women with low antioxidant status 2006 · supplementation group · Pregnant women screened positive for low antioxidant status at 8 to 12 weeks of gestation | 200 mg | — | — | 29 |
| A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia 2010 · NF group, 3-month blinded trial · Community-dwelling adults aged 18–86 years, both sexes, without dementia or clinical memory difficulties | 600 mg | 6 mcg | 90 days | 59 |
| A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia 2010 · Open-label NF group, separate 6-month trial · Community-dwelling adults, both sexes, without dementia or clinical memory difficulties | 600 mg | 6 mcg | 26 weeks | 38 |
| Effects of Macuprev(®) Supplementation in Age-Related Macular Degeneration: A Double-Blind Randomized Morpho-Functional Study Along 6 Months of Follow-Up 2019 · AMD-M group · Adults with intermediate age-related macular degeneration; 9 male and 21 female enrolled overall, mean age 69.32 years | 140 mg | 18 mg | 26 weeks | 15 |
| A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia 2010 · NF group, 2-week blinded trial · Community-dwelling adults, both sexes, without dementia or clinical memory difficulties | 600 mg | 6 mcg | 2 weeks | — |